Exabis Library
Welcome to the e-CCO Library!
P317: MaRIA score in the assessment of disease activity in patients with ileocolonic Crohn’s disease; the correlation between radiological, endoscopic, and clinical findings
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P317: Patient satisfaction in a joint fistula clinic at a tertiary Inflammatory Bowel Disease centre in the United Kingdom
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P317: Postoperative complications, outcome, quality of life and self-image after ileal pouch-anal anastomosis in patients operated due to acute, severe or chronic, therapy refractory ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P317: Societal cost-of-illness of Inflammatory Bowel Disease has rapidly increased over the years and differs between continents: A systematic review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P317: Ustekinumab Trough Concentrations Associated with Biochemical Outcomes in Patients with Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P318 Artificial intelligence of the neural network-assistant for differential diagnosis of IBD
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P318: Accuracy of magnetic resonance enterography for extraluminal complications of Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P318: Association between faecal calprotectin values and infliximab trough levels in inflammatory bowel disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P318: Does anti-tumour necrosis factor therapy decrease the risk of initial intestinal resection after the diagnosis of Crohn’s disease? A retrospective single-centre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P318: Intra-dermal with topical imiquimod pre-treatment versus intra-muscular hepatitis B vaccination in inflammatory bowel disease patients: a double-blind randomized controlled trial
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P318: Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P318: Safety of Biological Therapies in Elderly IBD: a Systematic Review and Meta-analysis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P318: Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P319 Clinical characteristics of patients with inflammatory bowel disease and metabolic syndrome
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P319: Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P319: Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P319: Combining anti-inflammatory treatment with antiviral treatment in severe cytomegalovirus-positive ulcerative colitis does not affect colectomy rate: a retrospective European multicentre study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P319: Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P319: Incorporating HLADQA1*05 in pre-biologic screening in IBD patients initiating biologic therapies
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P319: Long-term outcomes after anti-TNF therapy withdrawal in patients with radiologically healed perianal Crohn’s fistulas
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM